Form 4 for TXG 10x Genomics, Inc.
Accepted 2021-07-06 00:00:00 ET · period of report 2021-07-01 · accession 0001209191-21-045475 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2021-07-06 | 2021-07-01 | TXG | McAnear Justin J. | CFO | S - Sale+OE | $191.56 | -10.0K | 40.2K | -20% | -$1.92M |
| D | 2021-07-06 | 2021-07-01 | TXG | McAnear Justin J. | CFO | M - OptEx | $5.04 | +10.0K | 49.4K | +25% | +$50.4K |
| D | 2021-07-06 | 2021-07-01 | TXG | McAnear Justin J. | CFO | M - OptEx | $0.00 | -10.0K | 410.2K | -2% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2021-07-01 | S | D | 800 | $192.95 | 41,570 | D | — | — | (F6) This transaction was executed in multiple trades at prices ranging from $192.32 to $193.31. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. |
| 2 | Common | Class A Common Stock | 2021-07-01 | S | D | 700 | $194.81 | 39,470 | D | — | — | (F8) This transaction was executed in multiple trades at prices ranging from $194.40 to $195.39. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. |
| 3 | Common | Class A Common Stock | 2021-07-01 | S | D | 100 | $195.82 | 39,370 | D | — | — | |
| 4 | Common | Class A Common Stock | 2021-07-01 | S | D | 1,500 | $191.73 | 42,370 | D | — | — | (F5) This transaction was executed in multiple trades at prices ranging from $191.32 to $192.29. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. |
| 5 | Common | Class A Common Stock | 2021-07-01 | S | D | 2,800 | $190.66 | 43,870 | D | — | — | (F4) This transaction was executed in multiple trades at prices ranging from $190.25 to $191.22. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. |
| 6 | Common | Class A Common Stock | 2021-07-01 | S | D | 2,700 | $189.85 | 46,670 | D | — | — | (F3) This transaction was executed in multiple trades at prices ranging from $189.24 to $190.18. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. |
| 7 | Common | Class A Common Stock | 2021-07-01 | M | A | 10,000 | $5.04 | 49,370 | D | — | — | (F2) Includes an aggregate of 359 shares previously acquired under the Issuer's 2019 Employee Stock Purchase Plan. |
| 8 | Common | Class A Common Stock | 2021-07-01 | S | D | 1,400 | $193.76 | 40,170 | D | — | — | (F7) This transaction was executed in multiple trades at prices ranging from $193.38 to $194.35. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. |
| 9 | Derivative | Stock Option (right to buy) | 2021-07-01 | M | D | 10,000 | $0.00 | 410,159 | D | $5.04 · — to 2028-11-02 | 10,000 Class A Common Stock | (F9) This option, originally for 600,000 shares, of which 189,841 shares have been exercised, vested as to one-fourth of the shares on October 8, 2019 and one forty-eighth of the shares subject to the option vest each month thereafter, subject to the Reporting Person continuing as a service provider through each such date. |